Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-017457

Senior Vice President and CFO sold 16,750 shares at an average $7.54 ($126,325)

  • Senior Vice President and CFO acquired 16,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-02 Exercise or conversion : show line 1 in the form +7,750 $5.51 $42,703 140,426 D
2019-05-02 Sale : show line 2 in the form −7,750 $7.30 $56,575 132,676 D
2019-05-06 Exercise or conversion : show line 3 in the form +9,000 $5.51 $49,590 141,676 D
2019-05-06 Sale : show line 4 in the form −9,000 $7.75 $69,750 132,676 D
Open-market sales · 16,750 sh · avg $7.54 · $126,325

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-05-02 Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) −7,750 159,750 D
2019-05-06 Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) −9,000 150,750 D
Loading xslF345X03/form4.xml…